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repair of DNA damage, which all play an
important role in defining of epidermal
cell fate.
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Although growing evidence indicates that bioener-
getic metabolism plays an important role in the
progression of tumorigenesis, little information is
available on the contribution of reprogramming of
energy metabolism in cancer initiation. By applying
a quantitative proteomic approach and targeted me-
tabolomics, we find that specificmetabolic modifica-
tions precede primary skin tumor formation. Using a
multistage model of ultraviolet B (UVB) radiation-
induced skin cancer, we show that glycolysis, tricar-
boxylic acid (TCA) cycle, and fatty acid b-oxidation
are decreased at a very early stage of photocarcino-
genesis, while the distal part of the electron transport
chain (ETC) is upregulated. Reductive glutamine
metabolism and the activity of dihydroorotate dehy-
drogenase (DHODH) are both necessary for main-
taining high ETC. Mice with decreased DHODH activ-
ity or impaired ETC failed to develop pre-malignant
and malignant lesions. DHODH activity represents a
major link between DNA repair efficiency and bioen-
ergetic patterning during skin carcinogenesis.
INTRODUCTION
The most common metabolic hallmark of malignant tumors (i.e.,
the ‘‘Warburg effect’’) is their propensity tometabolize glucose to
lactic acid at a high rate even in the presence of oxygen.
Increased glucose uptake usually reflects an increased rate of
glycolysis, with conversion of glucose to lactate and decreased
utilization of pyruvate for mitochondrial oxidative phosphoryla-Cell
This is an open access article undtion (OXPHOS) (Liberti and Locasale, 2016; Zong et al., 2016).
Since the seminal studies of Otto Warburg one century ago,
biochemical research on cancer cell metabolism has revealed
the highly metabolic plasticity of cancer cells. A large number
of metabolic profiles have been discovered, from the highly
glycolytic phenotype repeatedly observed on fast-growing cell
lines (Vander Heiden et al., 2009; Ward and Thompson, 2012)
to the completely opposite profile characterized by a higher de-
pendency on OXPHOS, as found in metastasis (Porporato et al.,
2014) or a subclass of diffuse B cell lymphomas (Caro et al.,
2012). It is now widely accepted that OXPHOS and glycolysis
cooperate to sustain the energy demands of cancer cells (Smol-
kova´ et al., 2011; Ward and Thompson, 2012) and that cancer
cells undergo metabolic reprogramming to maintain anabolism
through various mechanisms including the deviation of glycol-
ysis, Krebs cycle truncation, and OXPHOS redirection toward
lipid and protein synthesis (Jose et al., 2011; Pavlova and
Thompson, 2016). The critical role of mitochondria in carcino-
genesis and gene regulation was further evidenced by recent
studies on various oncometabolites produced by the tricarbox-
ylic acid (TCA) cycle (Galluzzi et al., 2013; Ward and Thompson,
2012) and by the role of glutaminolysis, a biochemical pathway
located in mitochondria (Villar et al., 2015). A better understand-
ing of what determines tumor bioenergetics is also crucial for
developing adapted metabolic therapies, as currently proposed
for isocitrate dehydrogenase (IDH) 1 and 2mutant tumors (Emadi
et al., 2014; Seltzer et al., 2010).
Several genetic and biochemical mechanisms underlying the
bioenergetic profiling of tumors have been discovered in the
last decade (for review see Hosseini et al., 2017; Obre and Ros-
signol, 2015), but most of these findings were obtained on estab-
lished tumors or on mouse models of cancer progression.
Indeed, little attention has been given to the bioenergetic
profiling of the cancer initiation phase and how it influencesReports 23, 3621–3634, June 19, 2018 ª 2018 The Author(s). 3621
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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further the bioenergetic behavior of tumors. In the present study,
we investigated whether metabolic changes could be detected
at the initial stages before typical pathological alterations of
carcinogenesis occur, the impact of early metabolic changes in
skin tumor formation, and whether these changes can be main-
tained throughout tumor development. Solar ultraviolet B (UVB)
radiation is the primary environmental risk factor responsible
for the induction of non-melanoma skin cancers (NMSC)
including basal cell carcinomas (BCCs) and squamous cell car-
cinomas (SCCs), the most common types of human malig-
nancies worldwide. An estimate 5.4 million cases of NMSCs
were affecting 3.3 million patients among the US population in
2012 (Rogers et al., 2015). A major deleterious effect of UVB is
the induction of well-defined structural alterations in DNA, which,
in turn, trigger the DNA damage response (DDR) network. DDR
involves sensing the damage and then transducing this signal
to downstream effectors that elicit the appropriate responses
including repair of DNA damage, cell-cycle delay, senescence,
and/or apoptosis (Lagerwerf et al., 2011; Surova and Zhivotov-
sky, 2013). The ultimate fate of cells with damaged DNA is,
indeed, dependent on the type and extent of damage and
DNA repair capacity (Branzei and Foiani, 2008; Surova and
Zhivotovsky, 2013). If not repaired or if misrepaired, UVB-
induced DNA damage can ultimately contribute to the develop-
ment of skin cancers.
In the current study, we show that chronic UVB irradiation re-
sults in energy metabolism reprogramming through activation of
dihydroorotate dehydrogenase (DHODH) in the initial phase of
carcinogenesis. In turn, upregulated DHODH and activated
reductive glutamine metabolism work in concert to induce
electron transport chain (ETC) activation and pyrimidine synthe-
sis. Defects in these UVB-induced coordinated modifications,
through inhibition of DHODH or ETC impairment, block neoplastic
transformation of keratinocytes. These results demonstrate that
metabolic changes precede tumor formation and that ETC activity
plays a pivotal role in UVB-induced carcinogenesis.
RESULTS
Specific Reprogramming of the Metabolic Network
Occurs at a Very Early Stage of Skin Carcinogenesis
It is now widely accepted that tumorigenesis is associated
with altered metabolism (Hanahan and Weinberg, 2011). WeFigure 1. Metabolic Profiles Are Very Similar among Epidermal Hyperp
(A) Histopathological alterations in the human skin at different stages of carcinog
(B) Skin biopsies were subjected to proteomic analysis. Scatterplots show co
and actinic keratosis (left), hyperplasia and peritumoral tissue (middle), and hyperp
N = 20 samples per group. Red, green, purple, blue, and orange points indica
biosynthesis, and purine and pyrimidine metabolism, respectively.
(C) SKH-1 hairless mice were exposed to 150mJ/cm2, corresponding to one mini
UVB irradiation (initial phase), mice did not displaymacroscopic anomalies. Precu
after 13 weeks of chronic irradiation. Of these AK, some progressed into squamou
of clinical lesions are shown: *actinic keratosis, **Bowen’s disease, ***invasive S
(D) Histological analysis at initial phase indicates moderate hyperplasia and no pa
promotion stage, histological analysis reveals greater epidermal hyperplasia con
and hyperchromatic. Scale bars, 50 mm.
(E) Skin biopsies of irradiated and non-irradiated mice were subjected to proteom
levels between indicated groups. Each color dot represents an individual proteinwondered whether metabolic reprogramming occurs during
the initial phase of carcinogenesis. To this end, we first charac-
terized the large-scale changes in the bioenergetic machinery
of human skin at different stages of carcinogenesis using a
quantitative label-free differential proteomic analysis of human
skin hyperplasia (initial phase), actinic keratoses (AK, promotion
phase), peritumoral skin, and squamous cell carcinomas (SCCs,
progression stage) (Figures 1A and 1B; Table S1). A detail of the
function of these proteins was obtained by performing a KEGG
pathway analysis of the data using the String software (https://
www.ncbi.nlm.nih.gov/pubmed/25352553). We found that the
changes in the topology of the metabolic pathways involved in
the energy metabolism were very similar between hyperplasic,
AK, and peritumoral tissue. Interestingly, the metabolic profile
of tumors was significantly different from that of pre-cancerous
lesions. Of note, there was a dramatic downregulation of the
enzymes involved in lipid biosynthesis and a substantial upregu-
lation of several enzymes involved in glycolysis (Figure 1B;
Table S1). Therefore, it was considered likely that specific meta-
bolic modifications, of which some persist throughout tumor
development, occur at a very early stage of skin carcinogenesis.
An in vivomodel was then used to examine the mechanisms un-
derlying those early metabolic changes. To this end, SKH-1 hair-
less mice, which closely mimic photocarcinogenesis in humans
(DiGiovanni, 1992), were exposed to chronic UVB irradiation.
As seen in Figures 1C and 1D, different stages (initiation, promo-
tion, and progression) of skin carcinogenesis were easily evi-
denced at different times after chronic UVB irradiation. Indeed,
during the first few weeks of chronic UVB irradiation, mice pre-
sented moderate hyperplasia and no papillomatosis. Mild nu-
clear atypia was observed within basal keratinocytes. These
modifications were subtle and were only identified histologically.
Mice started to develop pre-malignant AK-like lesions (promo-
tion stage) after 13 weeks of chronic irradiation. At that time,
greater cellular atypia and epidermal hyperplasia were also
observed. Of these AK, some progressed into small keratotic
and large ulcerated tumors resembling human SCCs (progres-
sion stage), with the potential for metastatic spread after
20 weeks of UVB irradiation (Figures 1C and 1D).We then
compared the metabolic changes described by the proteomic
analysis of skin hyperplasia, AK, peritumoral skin, and full-blown
SCC (Figure 1E; Table S2). The changes in the topology of the
metabolic pathways involved in the energy metabolism atlasia, Actinic Keratosis, and Peritumoral Tissue
enesis were evaluated with H&E staining. Scale bars, 50 mm.
mparison of fold change of protein expression levels between hyperplasia
lasia and full-blown SCC (right). Each color dot represents an individual protein.
te the proteins involved in glycolysis, TCA cycle, fatty acid b-oxidation, lipid
mal erythemal dose, three times per week. During the first few weeks of chronic
rsor lesions known as actinic keratoses (AK, promotion stage) started to appear
s cell carcinoma (SCC), in situ (Bowen’s disease), and invasive SCC. Examples
CC.
pillomatosis. Mild nuclear atypia is also observed within basal keratinocytes. At
sisting of keratinocytes manifesting atypical nuclei that are enlarged, irregular,
ic analysis. Scatterplots show comparison of fold change of protein expression
. N = 12 samples per group
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Figure 2. UVB Irradiation Downregulates
the Majority of Proteins Involved in Glycol-
ysis, TCA Cycle, and Fatty Acid b-Oxidation
Proteomic analysis was used to investigate the
effects of chronic UVB irradiation on the profile
expression of several proteins in skin biopsies of
SKH-1 mice. To this end, skin biopsies of mice
irradiated for 2 months (Ir) and non-irradiated (nIr)
counterparts were subjected to proteomic anal-
ysis. The quantity of each protein involved in
glycolysis, TCA cycle (A), fatty acid b-oxidation (B),
and electron transport chain (ETC) (C) was
compared between Ir and nIr groups and the re-
sults are expressed as mean fold change of
expression of each protein. N = 8 mice per group.
ACAD, acyl-CoA dehydrogenase; ACAD(VL, L and
S), very long-, long-, and short-chain-specific
acyl-CoA dehydrogenase; ACO, aconitate hydra-
tase; ATP5, ATP synthase; COX, cytochrome C
oxidase; CS, citrate synthase; ENO3, beta-
enolase; ETF(A and B), electron transfer flavopro-
tein (alpha and beta); ETFDH, ETF-ubiquinone
oxidoreductase; FH, fumarate hydratase; GPI,
glucose-6-phosphate isomerase; HADH, hydrox-
yacyl-CoA dehydrogenase/3-ketoacyl-CoA thio-
lase/enoyl-CoA hydratase; HK, hexokinase;
IDH, isocitrate dehydrogenase; LDH, L-lactate
dehydrogenase; MDH, malate dehydrogenase;
NDUF, NADH dehydrogenase (ubiquinone);
OGDH, 2-oxoglutarate dehydrogenase; PDH, py-
ruvate dehydrogenase; PFK(P, M, and L),
6-phosphofructokinase (platelet, muscle, and liver
type); PGAM, phosphoglycerate mutase; PGK,
phosphoglycerate kinase; PGM, phosphogluco-
mutase; PKM, pyruvate kinase; PYGM, glycogen
phosphorylase, muscle form; SDH, succinate de-
hydrogenase; SUCL, succinyl-CoA ligase; TPI,
triosephosphate isomerase; UQCR, ubiquinol-cy-
tochrome C reductase.different stages of photocarcinogenesis were very similar to
those found in human samples.
Focusing on metabolic changes of mouse skin exposed to
chronic UVB irradiation for 8 weeks (initial stage of carcinogen-
esis), the majority of proteins involved in the glycolysis, TCA cy-
cle, and fatty acid b-oxidation were shown to be significantly
decreased, respectively from 50% to 80%, from 36% to 58%,
and from 28% to 84%, in irradiated skin. On the contrary, irradi-
ation increased proteins involved in the distal part of the electron
transport chain (ETC) with overexpression values ranging from
2.02- to 5.57-fold (Figures 1E and 2; Table S2).
To further verify the effects of chronic UVB irradiation on en-
ergy metabolism, biochemical functional analyses were per-3624 Cell Reports 23, 3621–3634, June 19, 2018formed. Results revealed lower glucose
consumption and lactate production in
irradiated skin than in non-irradiated skin
(Figures 3A and 3B). To determine the ef-
fects of UVB irradiation on the metabolic
fates of glucose, [U-13C]-labeled glucose
(here U indicates uniformly labeled) was
injected intraperitoneally (i.p.) into twogroups of mice, and 13C enrichment of intracellular metabolites
was measured by mass spectrometry. In non-irradiated cells,
most citrate molecules (>60%) contained glucose-derived 13C
(Figures 3C and 3D). Citrate m+2 (citrate containing two addi-
tional mass units from 13C) results from oxidative decarboxyl-
ation of glucose-derived pyruvate by pyruvate dehydrogenase
(PDH) to form [1,2-13C]acetyl-coA, followed by condensation
with an unlabeled oxaloacetate (OAA). Processing of citrate
m+2 around one turn of the TCA produces citrate m+4 (Fig-
ure 3C). In irradiated skin, most citrate contained no glucose car-
bon (m+0), indicating significant reduction of PDH contribution to
acetyl-CoA (Figure 3C). Malate, fumarate and glutamate m+2
were also decreased in irradiated skin (Figures 3E and 3F).
Figure 3. UVB Irradiation Results in Down-
regulation of Glycolysis, TCA Cycle, and
Fatty Acid b-Oxidation and Overactivation
of Distal Part of OXPHOS
SKH-1mice exposed to chronic UVB irradiation for
8 weeks.
(A and B) The glucose uptake and lactate pro-
duction by skin biopsies taken from irradiated and
non-irradiated mice were measured. Skin biopsies
of irradiated mice consume less glucose (A) and
produce less lactate (B).
(C) Schematic depicting glucose carbon flow into
TCA metabolites. Black color represents labeled
carbon on 1st TCA cycle, green color represents
labeled carbon on 2nd TCA cycle, and blue color
represents labeled carbon on 3rd TCA cycle (C).
(D–F) Mass isotopomer analysis of citrate (D),
malate (E), and glutamate and fumarate (F) in skin
of irradiated and non-irradiated mice received
intraperitoneally [U-13C] labeled glucose.
(G) The respiratory capacity of skin biopsies taken
from irradiated and non-irradiated skin in the
presence of carnityl-palmitate as energy substrate
were measured. Kinetics of basal oxygen con-
sumption rate (OCR) response to palmitate in-
dicates a significant decrease in fatty acid oxida-
tion in irradiated skin biopsies. Etomoxir inhibits
fatty acid beta-oxidation by binding to carnitine
palmitoyltransferase and preventing entry of fatty
acids into the mitochondria.
(H) OCR and extracellular acidification rate (ECAR)
were determined using Seahorse XF24 Extracel-
lular Flux Analyzer in irradiated and non-irradiated
skin. UVB irradiation is associated with an
increased basal OCR and a decreased extracel-
lular acidification rate (ECAR).
(I) The maximal activities of mitochondrial com-
plexes II, III, and IV were measured in irradiated
and non-irradiated mice. UVB irradiation results in
over-activation of complexes III and IV.
(J) Basal OCR level was measured in skin samples
treated with mentioned inhibitors of mitochondrial
complexes. Increased OCR in UVB-irradiated skin
are blocked when samples are treated with in-
hibitors of complexes III and IV (i.e., antimycin and
sodium azide).
(K–M) UVB irradiation results in an increased
mitochondrial ATP content (K), elevation of ADP/
ATP ratio (L), and increased oligomycin-sensitive
respiration (the portion of respiration used for ATP
turnover) (M).
Results are presented as means ± SD. N = 15 mice (A, B, and G–M) and 6 mice (D–F) for each group. *p < 0.05 and ** < 0.01 for irradiated versus non-irradiated
mice. O p < 0.05 and OO p < 0.01for treated versus non-treated irradiated mice. Dig, digitonin; Oligo, oligomycin; DNP, 2,4-dinitrophenol.To assess the effects of UVB irradiation on fatty acid b-oxida-
tion, we measured the respiratory capacity of digitonin-permea-
bilized skin in the presence of carnityl-palmitate as energy sub-
strate. Irradiated skin was unable to trigger a substantial
switch to fatty acid oxidation when shifted from no-glucose to
palmitate-supplemented medium, reflected by a 1.40-fold lower
basal oxygen consumption rates (OCR) burst than that in non-
irradiated skin (Figure 3G).
To evaluate the OXPHOS activity following irradiation, basal
OCR was first measured. Results indicated that basal OCR ob-
tained in complete media was higher in irradiated skin than innon-irradiated skin (Figure 3H). The discrepancy between Fig-
ures 3G and 3H on the basal OCR in irradiated skin may be ex-
plained by the difference in themedium used. In fact, to measure
fatty acid oxidation capacity in Figure 3G, skin were placed in
minimal medium in which carnityl-palmitate was added after-
ward. On the contrary, to measure OXPHOS activity, skin was
placed in complete medium (see the Experimental Procedures
for details). To further determine the effect of chronic UVB irradi-
ation on OXPHOS activity and capacity, we first evaluated the
maximal activities of the different enzyme complexes. While
the activity of complex II was significantly diminished followingCell Reports 23, 3621–3634, June 19, 2018 3625
Figure 4. UVB Irradiation Triggers Reductive Glutamine Metabolism and Activation of DHODH that Drive Increased ETC Activation
(A) Relative abundance of indicated amino acids in skin biopsies of mice irradiated for 2 months (Ir) and non-irradiated (nIr) counterparts were quantified. All
measurements are relative to non-irradiated skin.
(legend continued on next page)
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irradiation, the activities of complexes II+III and IV weremarkedly
increased (Figure 3I), suggesting a specific increased utilization
of the distal part of ETC after UVB irradiation. This is in agree-
ment with inhibitor titration studies showing that rotenone and
malonate only decreased moderately the baseline OCR level in
irradiated skin, by 18% and 25%, respectively, while antimycin
and NaN3 reduced it by 81% and 70% (Figure 3J). These re-
sults suggested a major role for complexes III and IV in elevated
OCR in irradiated skin and a potential increased fueling of the
respiratory chain between complex II and complex III in irradi-
ated skin samples. We then verified that such increase in mito-
chondrial respiration was coupled to an increase in mitochon-
drial ATP content (Figure 3K). The ADP/ATP ratio in irradiated
skin was also higher than in non-irradiated mice, suggesting a
higher cellular energy demand in irradiated skin (Figure 3L).
Finally, the proportion of respiration used to produce ATP (the
oligomycin-sensitive respiration) was increased in irradiated
skin compared with non-irradiated skin (Figure 3M).
Consistent with the topology obtained by proteomic analysis,
biochemical functional analyses revealed that UVB irradiation re-
sults in (1) downregulation of glycolysis, TCA cycle, and fatty acid
b-oxidation, and (2) increased distal part of OXPHOS. Further-
more, these results indicate that a specific mode of electrons-
fueling to the ETC occurs following chronic irradiation.
Increased ETC Activity in Chronic UVB Irradiated Skin Is
Related to the Activity of DHODH and Reductive
Glutamine Metabolism
Downregulation of glycolysis, TCA cycle, and fatty acid b-oxida-
tion, despite maintenance of high OXPHOS, raised an important
question: which carbon source is exploited in irradiated skin for
maintaining OXPHOS. To answer this question, quantitative me-
tabolomics analysis of intracellular free amino acids was per-
formed. Among different amino acids, the abundance of gluta-
mate, glutamine, and aspartate were respectively 1.37-,1.45-,
and 1.39-fold higher in irradiated samples than in non-irradiated(B and C) Skin samples taken from irradiated and non-irradiated mice were incub
for 5 hr. Measurement of aspartate (B) and glutamine (C) uptake indicated irradiate
glutamine, and/or aspartate.
(D) Schematic depicting carbon atom (circles) transitions in oxidative (black arrow
(E–G) Mass isotopoloque analysis of citrate (E), malate (F), and aspartate (G) in no
glucose for 5 hr.
(H) Skin biopsies of mice nIr and Ir mice were subjected to proteomic analysis
compared between nIr and Ir groups, and the results are expressed as mean fol
(I) The protein expression level of DHODHwas determined bywestern blot. b-actin
protein level.
(J) The relative DHODH activity in irradiated and non-irradiated skin wasmeasured
treatment of mice with leflunomide (LFN), an inhibitor of DHODH.
(K) Isotopomer distribution of orotate from non-irradiated and irradiated cells cultu
that are derived from aspartate are shown in red.
(L) Percentage of orotate m+3 isotopologue was compared between siCtrl- and s
glucose ± LFN.
(M andN) Chronic UVB-irradiated and non-irradiatedmice received intraperitonea
determined and indicated that LFN treatment blocks UVB exposure-mediated inc
to dihydroorotic acid were assessed. UVB-irradiated skin samples display increa
Results are presented as means ± SD. N = 6 [(A-C, E-G, K)], 4 [L] and 12 [(I-J, M-
mice. d < 0.01 for treated samples versus corresponding basal OCR level.  p <
PRPP, phophoribosylpyrophosphate; CAD, carbamoyl-phosphate synthetase
DHODH, DHO dehydrogenase; OMP, orotidine 50-monophosphate; UMPS, uridicells (Figure 4A). To examine whether glutamine or aspartate flux
could provide an insight into biochemical processes occurring
within the irradiated cells, we measured the consumption rate
of glutamine and aspartate. Results revealed higher glutamine
consumption and lower aspartate consumption in irradiated
skin than in non-irradiated samples when cells were placed in
medium supplemented with glucose, glutamine, and aspartate
or in medium containing glutamine and aspartate. On the con-
trary, in the medium without glucose and glutamine, irradiated
cells had a higher consumption of aspartate than non-irradiated
cells (Figures 4B and 4C). To further define the metabolic fates of
glutamine, cells isolated from irradiated and non-irradiated mice
were cultured in medium supplemented with L[U-13C]glutamine.
While non-irradiated cells used glutamine through oxidative
glutamine metabolism, resulting in formation of citrate and ma-
late m+4 (Figures 4D and 4F), irradiated cells produced mainly
citrate m+5 and malate m+3 through reductive carboxylation of
glutamine-derived a-ketoglutarate (Figures 4D–4F). Moreover,
irradiated cells contained abundant aspartate m+3, which was
essentially absent from non-irradiated cells (Figure 4G), indi-
cating that irradiated cells used preferentially reductive gluta-
mine metabolism to provide aspartate.
To understand the link between the stimulation of distal part of
ETC and increased consumption of glutamine following irradia-
tion, we performed a search on the proteomic data. We found
that the enzymes involved in pyrimidine synthesis, in which
glutamine and aspartate are used as key anaplerotic substrates,
weremarkedly increased in irradiated skin compared to non-irra-
diated skin (Figure 4H). Because DHODH is the only mitochon-
drial enzyme of this pathway that converts dihydroorotate to or-
otate coupled with the reduction of ubiquinone to ubiquinol, we
wondered whether DHODH is the link between increased gluta-
mine and oxygen consumption in irradiated cells. To test this hy-
pothesis, we first measured the expression and activity of
DHODH in irradiated and non-irradiated mice. DHODH protein
expression level as well as enzyme activity were markedlyated DMEM medium supplemented with glucose, glutamine, and/or aspartate
d skin consume less aspartate andmore glutamine in the presence of glucose,
s) and reductive (green arrows) glutamine metabolism using [U-13C] glutamine.
n-irradiated and irradiated cells cultured with [U-13C] glutamine and unlabeled
. The quantity of each protein involved in de novo pyrimidine synthesis was
d change of expression of each protein.
was used as a loading control. UVB irradiation leads to upregulation of DHODH
. IncreasedDHODH activity in UVB-irradiated skin samples is blocked following
red with [U-13C]glutamine and unlabeled glucose for 5 hr. Left: atoms of orotate
iDHODH-transfected cells cultured for 5 hr with L[U-13C] glutamine + unlabeled
l injection of placebo or LFN 2 hr prior to sacrifice. TheOCRof skin biopsies was
reased basal OCR in mouse skin (M). Kinetics of OCR response of skin biopsies
sed OCR level upon supplementation with 10 mM dihydroorotic acid (N).
N)] mice per group. *p < 0.05 and ** < 0.01 for irradiated versus non-irradiated
0.01 for LFN-treated irradiated mice versus placebo-treated irradiated mice.
2, aspartate transcarbamylase, and dihydroorotase; CTPS1, CTP synthase;
ne 50-monophosphate synthase.
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upregulated in irradiated skin (Figures 4I and 4J). To examine
whether glutamine-derived aspartate contributes to pyrimidine
synthesis, epidermal cells isolated from non-irradiated and irra-
diatedmicewere incubated for 5 hr in themedium supplemented
with labeled [U-13C] glutamine. Results indicated that in contrast
to non-irradiated skin, irradiated cells contained abundant
labeledm+3 orotate, a central intermediate of pyrimidine synthe-
sis (Figure 4K). To confirm that the contribution of glutamine-
derived aspartate to orotate synthesis is dependent on DHODH
activity, epidermal cells were transfected with siDHODH, prior to
culturing in the medium supplemented with labeled [U-13C]
glutamine ± leflunomide (LFN, 50 mM), a potent but non-specific
inhibitor of DHODH and a FDA-approved drug for the treatment
of rheumatoid arthritis. Results indicated that the entry of aspar-
tate-derived 13C into orotate was abolished in both LFN-treated
and siDHODH-transfected cells (Figure 4L).
We then investigated the link between DHODH and ETC acti-
vation. To examine whether increased oxygen consumption in
irradiated skin was dependent on DHODH activity, one group
of chronic UVB-irradiated mice received intraperitoneally LFN
(20 mg/kg/day), 2 hr prior to sacrifice. Baseline OCR levels
were dramatically decreased when irradiated mice received
LFN (Figure 4M). In contrast, a significant increase in ETC utiliza-
tion was noted when irradiated skin was supplemented with di-
hydroorotic acid (Figures 4N and S1). To further confirm the ef-
fect of DHODH on oxygen consumption, OCR were measured
in siDHODH-transfected keratinocytes isolated from irradiated
or non-irradiated skin. DHODH downregulation led to a signifi-
cant decrease in basal OCR levels (Figure S2A).
To survey the effect of DHODH on the observed increase in
complex III activity, the activities of complexes II+III were
measured in siDHODH-transfected keratinocytes isolated from
irradiated or non-irradiated skin as well as in the presence of
LFN (50 mM). Inhibition or downregulation of DHODH blocked
over-activation of complexes II+III in UVB-irradiated skin (Fig-
ure S2B). Finally, to examine whether glutamine, aspartate, and
DHODH are needed for maintenance of the high OXPHOS in irra-
diated skin, keratinocytes isolated from irradiated or non-irradi-
ated skin were transfected with siDHODH or siCtrl. These cells
were then incubated in DMEM medium without glucose, gluta-
mine, and aspartate for 2 hr. Basal OCR were then measured
following addition of glucose (5 mM) ± glutamine (5 mM) and
aspartate (5 mM) in medium. Results indicated that basal OCR
obtained in media supplemented with glutamine and aspartate
was higher in irradiated skin than in non-irradiated skin (Fig-
ure S2C). Furthermore, the upregulation of OCR in irradiated cells
was dependent on the DHODH expression (Figure S2C).
Overall, our results show that reductive glutamine metabolism
and DHODH activity are both necessary to maintain high
OXPHOS in irradiated cells.
Inhibition of DHODH Activity or Global Downregulation
of ETC Results in Hypersensitivity to UVB Exposure
To evaluate the impact of DHODH upregulation and ETC activa-
tion on UVB-induced skin carcinogenesis, we used the following
approaches: (1) the inhibition of DHODH using LFN, and (2) a
mouse model of inducible Tfam knockout targeted to keratino-
cytes (K14-Cre-ERT2/Tfamflox/flox). The Tfam knockout model3628 Cell Reports 23, 3621–3634, June 19, 2018was chosen because TFAM is the main regulator of mtDNA tran-
scription and consequently of the mitochondrial genes encoding
ETC subunits (Campbell et al., 2012; Kang et al., 2007). As seen
in Figure 5A, while the expression of mitochondrial-encoded
NADH dehydrogenase 1 (MT-ND1), cytochrome c oxidase 1
(MT-CO1), and ATP synthase 6 (MT-ATP6) proteins were signif-
icantly reduced in Tfam-ablated mice, the expression of nuclear-
encoded mitochondrial complex 1 subunit NDUFB8, II subunit
SDHB, III subunit UQCRC2, and V subunit ATP5A did not
change. Moreover, there was a marked reduction in DHODH
expression and activity in the skin of Tfam-ablated mice (Figures
5A and 5B), suggesting a complex link between OXPHOS genes
and DHODH expression. To further explore this relationship, ker-
atinocytes were treated with pharmacological activators of mito-
chondrial biogenesis (AICAR and resveratrol) or inducers of the
retrograde response using OXPHOS blockers (Rotenone, anti-
mycin, DNP). Assessment of the DHODH expression and activity
revealed that DHODH was a part of a general program of mito-
chondrial biogenesis (Figures S3A and S3B). We developed an
inducible mousemodel becausemice with epidermal Tfam abla-
tion (K14-Cre/Tfamflox/flox) have been shown to have a short life-
span owing to malnutrition (insufficient milk intake) (Baris et al.,
2011). To avoid the effect on nutrition, Tfam was ablated by
topical skin application of tamoxifen in keratinocytes of K14-
Cre-ERT2/Tfamflox/flox mice, hereinafter called K-Tfam/. As
controls, we used tamoxifen-treated K14-Cre-ERT2 mice, here-
inafter referred to as K-Tfam+/+. Because there were no mean-
ingful differences in outcome between mice receiving LFN and
K-Tfam/ mice, hereinafter only the results of K-Tfam+/+ and
K-Tfam/ are shown.
We first monitored LFN-treated and K-Tfam/ mice and their
control counterparts during the first 4 months of life. The mice
developed normally and histological analysis of skin revealed a
normal epidermis with no obvious abnormality in epidermal dif-
ferentiation or proliferation (Figure 5C), in contrast with impaired
epidermal differentiation noted in the epidermal constitutionally
deleted Tfam mouse (Hamanaka et al., 2013). These mice were
then exposed to chronic UVB irradiation. The LFN-treated and
K-Tfam/ mice exhibited a UVB-related phenotype very early
(Figure 6A). Indeed, 9 out of the 15 K-Tfam/ and 8 out of the
12 LFN-treated mice exhibited thick squamous hyperkeratotic
plaques 12 weeks after UVB irradiation (Figure 6B). In 2 out of
the 9 K-Tfam/ mice, stratum corneum sloughing of a large
part of the dorsal skin was also noticed. Twenty weeks after
chronic UVB irradiation, all of these mice presented desquama-
tive features with a hyperkeratotic epidermis (Figure 6B). How-
ever, none of them developed AK and/or keratotic tumors up
to 30 weeks after irradiation (Figures 6B and 6C). In contrast,
none of the control mice had any obvious abnormality up to
week 12 after irradiation, and 8 out of the 15 K-Tfam+/+ exhibited
at least one AK lesion at 18 weeks (Figures 6A–6D). To further
determine that hyperkeratotic plaques did not have tumorigenic
potential, one group ofmicewas kept under observation (without
further UVB exposure) following 20 weeks of chronic UVB
irradiation. While tumors developed on the back of K-Tfam+/+
mice and new tumors continued to appear over time (Figures
6E and 6F), hyperkeratotic plaques healed, and no tumors
were detected on K-Tfam/ mice (Figures 6E and 6G).
Figure 5. UVB Exposure-Mediated DHODH
Activation Is Blocked upon Epidermal Abla-
tion of Mitochondrial Transcription Factor
A (Tfam)
(A) Total protein extracts of skin biopsies were
assessed for expression of mitochondrial-en-
coded enzymes and DHODH by western blot.
b-Actin was used as a loading control.
(B) Epidermal ablation of Tfam results in down-
regulation of DHODH activity. Results are pre-
sented as means ± SD.
(C) Tfam-ablated mice (K-Tfam/) and their con-
trol counterparts (K-Tfam+/+) were subjected to
chronic UVB irradiation and skin biopsies were
taken at indicated times. Histopathology of
epidermis was evaluated with H&E staining. Dif-
ferentiation status of epidermis was assessed us-
ing immunofluorescence staining of K10, filaggrin,
and loricrin. Proliferation was evaluated by Ki67
immunostaining. The nuclei were marked in blue
with DAPI. **<0.01 for irradiated versus non-irra-
diated WT mice. Scale bars, 50 mm.Histological examination demonstrated that while K-Tfam+/+
mice at 12 weeks after irradiation presented moderate hyper-
plasia and no papillomatosis, K-Tfam/mice presented a papil-
lomatous epidermal hyperplasia, hyperkeratosis showing crusts
and parakeratosis, and no dermal invasion. Twenty-five weeks
after irradiation, while K-Tfam+/+ mice presented typical small
cell invasive and moderately differentiated SCC, K-Tfam/ pre-
sented papillomatous hyperplasia and hyperkeratosis with para-
keratosis, without dermal invasion (Figure 5C).
Because DHODH is a key player in the pyrimidine de novo
biosynthesis pathway, we wondered whether DHODH inhibition
and Tfam ablation might affect DNA repair efficiency. To confirm
this hypothesis, the level of cyclopyrimidine dimer (CPD) was first
quantified by immuno-dot blot in DNA of the different groups of
mice irradiated for 12 weeks. The CPD level was much higher in
leflunomide-treated and K-Tfam/mice than in K-Tfam+/+ mice
(Figure 6H). Quantification of CPD in the genome of mice by
HPLC-MS/MS revealed that the CPD level was respectively
1.82- and 1.74-fold higher in leflunomide-treated and K-Tfam/Cell Rmice than in K-Tfam+/+ mice (Figure 6I).
We thenmeasured the DNA repair capac-
ity of skin mouse samples. To this end, we
added the skin protein extracts on a fixed
plasmid harboring a defined quantity of
CPD. In this assay, the capacity of CPD
excision and the re-synthesis of the
excised strand is directly correlated with
the incorporation of labeled nucleotides.
Results indicated a 40% and 54%
reduction in CPD repair in leflunomide-
treated and K-Tfam/ mice, respec-
tively, as compared with K-Tfam+/+ mice
(Figure 6J).
Because UVB-induced apoptosis is a
key determinant affecting the ultimate
fate of cells with damaged DNA(Lagerwerf et al., 2011; Surova and Zhivotovsky, 2013), we eval-
uated the effect of Tfam ablation on apoptosis. Western blotting
revealed that chronic UVB exposure of Tfam/mice resulted in
an imbalance between proapoptotic (BAX and BAD) and antia-
poptotic (BCL-XL and BCL-2) proteins in favor of the former,
leading to induction of apoptosis (Figure 6K). Consistently,
increased cleaved caspase-3 level (Figures 6K and 6L) and
higher caspase-3 activity were found in UVB-irradiated
K-Tfam/ mice (Figure 6M). We next examined the effect of
Tfam ablation on cell-cycle progression. Western blotting re-
vealed that the positive cell-cycle regulators, namely CDK4,
CDK6, CDC25C, cyclin B, cyclin D1, and cyclin E were upregu-
lated upon irradiation, and their expressions were higher in
K-Tfam+/+ mice than in K-Tfam/ mice (Figure S4A). The nega-
tive cell-cycle regulators, namely p16 et p21WAF1, were
increased upon irradiation more pronouncedly in K-Tfam/
mice than in K-Tfam+/+ mice. Higher levels of phosphorylated
ataxia telangiectasia-mutated and Rad3-related (ATR) and
phosphorylated CHK1 in irradiated K-Tfam/ mice comparedeports 23, 3621–3634, June 19, 2018 3629
Figure 6. A Keratinocyte-Specific Knockout of Tfam Results in Early UVB Exposure Phenotype without Tumor Formation
(A–D) Tfam-ablated mice (K-Tfam/) and their control counterparts (K-Tfam+/+) were subjected to chronic UVB irradiation. On K-Tfam+/+ mice, variable numbers
of tumors of variable size that are mostly ulcerated are visible. Some mild pigmentation of UV treated areas is also observed on some mice. The backs of
K-Tfam/mice are covered by a large squame with evidence of peripheral desquamation and there is also evidence of punctiform or larger erosions in the larger
(legend continued on next page)
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with irradiated K-Tfam+/+ mice (Figure S4A) suggested that
decreased DNA repair efficiency and subsequently accumula-
tion of DNA damage in Tfam-ablated mice possibly delayed
the cell-cycle progression and caused increased apoptotic
cell death. In line with this hypothesis, colony formation assay,
in which the number and size of colonies reflect growth potential
of cells, revealed lower proliferation potential of keratinocytes in
irradiated Tfam/ compared to Tfam+/+ (Figures S4B and S4C).
To further determine whether the observed hypersensitivity to
UVB in Tfam-ablated mice is fully dependent on TFAM-DHODH
activity-pyrimidine biosynthesis axis, K-Tfam/ mice were
received i.p. injection of exogenous uridine (100 mg/kg/day).
Assessment of proliferation potential of keratinocytes (Figures
S4B and S4C), tumor development (Figures S4D–S4F), CPD
quantity (Figure S4G), and apoptosis level (Figure S4H) revealed
that pyrimidine supplementation largely reversed the observed
hypersensitivity to UVB in Tfam-ablated mice.
Altogether, these results strongly suggest that the paradoxical
absence of tumor formation in Tfam-ablated mice despite the
early aggressive UVB exposure phenotype could be related to
the decreased pyrimidine biosynthesis and subsequently
decreased DNA repair capacity and increased apoptotic cell
death.
DHODH Upregulation Persists at Different Stages
of Skin Carcinogenesis
We next studied the expression and the activity of DHODH at
different stages of carcinogenesis. DHODH was upregulated at
a very early phase of UVB-induced tumorigenesis (i.e., hyper-
plasia), and this upregulation persisted during the subsequent
steps of carcinogenesis (Figures 7A and 7B).
We finally investigated DHODH expression and activity in hu-
man skin at different stages of carcinogenesis. To this end, we
first evaluated the expression of DHODH in skin specimens
from healthy individuals, hyperplasia, AK, Bowen’s disease,
and invasive SCC (Figures 7C and 7D). Immunostaining showed
that DHODH was mainly expressed in the basal layer of the
epidermis in healthy skin. However, epidermal hyperplasia, AK,
Bowen’s disease, and invasive SCC specimens displayed
diffuse cytoplasmic staining. Of note, the basal keratinocytes
in hyperplasia and AK had a higher expression of DHODH
compared with other keratinocytes in these specimens. We
then assessed the activity of DHODH in skin specimens from
healthy individuals, AK, peri-tumoral skin, Bowen’s disease,
and invasive SCC. Results showed that DHODH activity wassquamous lesions. Mild erythema and pigmentation are also observed on squam
(B), the number (C), and the volume (D) of tumors per mouse were assessed (me
(E–G) At week 20, chronic UVB exposure was stopped and mice were monitore
plaqueswere restored and no tumorswere detected on K-Tfam/mice (G). O p <
(i.e., the first point).
(H and I) Immuno-dot blot (H) and HPLC-MS/MS (I) analysis indicate that the qua
mice and LFN-treated mice upon chronic UVB irradiation than in control mice.
(J) The capacity of CPD excision and the re-synthesis is lower in Tfam-ablated o
(K–M) Assessment of protein expression level of pro- and antiapoptotic proteins b
indicates increased apoptotic cell death induction in irradiated K-Tfam/ mice c
Results are presented as means ± SD. N = 15 (A–D) and (H–K) and 6 (E–G) mice
Tfam+/+ mice at corresponding time points. O p < 0.05 and OO p < 0.005 for indhigher in the different stages of carcinogenesis compared to
healthy skin (Figure 7E).
DISCUSSION
This study provides insights into the understanding of UVB-
induced skin cancer and emphasizes the pivotal role of energy
metabolism. We demonstrate that UVB-induced DHODH activa-
tion and reductive glutaminemetabolism both participate inmain-
taining nucleotide biosynthesis and cell proliferation, thus para-
doxically favoring the development of SCCs. Our data clearly
show that LFN-treated mice and TFAM-deficient mice manifest
a specific type of hypersensitivity to UVB. However, these mice
develop neither actinic keratosis nor skin tumors, even after
cessation of UV exposure. Beyond the basic understanding of
UVB-induced tumor formation, our findings have substantial
implications for the development of new therapeutics for precan-
cerous lesions and established skin cancers, SCC type.
In addition to contributing to amino acid and lipid biosynthesis,
mitochondrial metabolism affects nucleotide biosynthesis.
Indeed, many components that contribute to both pyrimidine
and purine bases are derived directly or indirectly from mito-
chondria. Besides glutamine and aspartate, which can be sup-
plied by mitochondria, pyrimidine synthesis requires the activity
of the mitochondrial enzyme DHODH, linking cellular respiration
and pyrimidine synthesis directly (Ahn andMetallo, 2015). In sup-
port of this notion, our results indicate that oxygen consumption
rate, reductive glutamine metabolism, pyrimidine synthesis, and
efficient repair of DNA damage are all dependent on DHODH ac-
tivity in irradiated skin (see Figures 4L–4N, 6, and S2A–S2C).
While respiration is thought to primarily support ATP production
and regeneration of electron acceptors (e.g., NAD+ and FAD+)
(Sullivan et al., 2015; Titov et al., 2016), appearance of tumors
and rescue of hypersensitivity to UVB in Tfam-ablated mice
upon uridine supplementation revealed that respiration is specif-
ically required for nucleotide biosynthesis upon irradiation, high-
lighting a distinct anabolic role for respiration in this condition.
Consistently, it has been shown that pyrimidine nucleotide levels
are increased in cells in response to other genotoxic stressors
such as chemotherapy agents. This upregulation of pyrimidine
biosynthesis could be considered as a metabolic vulnerability
that can be exploited to enhance the efficacy of chemotherapy
and to decrease emergence of resistance, as recently proposed
for using doxorubicin and LFN as a promising combination ther-
apy in breast cancer (Brown et al., 2017).ous areas (A). The number of mice harboring desquamative features or tumors
an ± SD) at indicated times.
d for one more month (E). While tumors grew on K-Tfam+/+ (F), hyperkeratic
0.05 andOOp< 0.005 for indicated time points versus stopped irradiation state
ntity of cyclopyrimidine dimer (CPD) is higher in skin samples of Tfam-ablated
r LFN-treated mice than in control mice.
y western blotting (K), cleaved caspase-3 expression (L), and caspase-3 activity
ompared with control counterparts (M)
per group. *p < 0.05 and ** < 0.01 for irradiated K-Tfam/ versus irradiated K-
icated time points versus stopped irradiation state (i.e., the first point).
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Figure 7. DHODH Upregulation Persists at Different Stages of Skin Carcinogenesis
(A and B) The expression and the activity of DHODH were assessed in mouse skin specimens at different stages of tumorigenesis. Upregulation of DHODH
expression (A) and its activity (B) persists at different stages of UVB-induced carcinogenesis. The mean value of DHODH activity in non-irradiated skin samples
was set at 1. The results were then compared with this point. Each point corresponds to an individual sample and bars indicate mean values (N = 50 samples per
group).
(C and D) DHODH expression was assessed in human skin specimens at different stages of tumorigenesis. Scale bars, 50 mm (C). Graph shows quantification of
DHODH staining intensity (0 = no staining to 3 = high staining) in skin sections excluding the basal layer cells (D).
(E) DHODH activity was evaluated in human skin specimens. The mean value of DHODH activity in normal human skin was arbitrarily set at 1. The results were
then compared with this point. Each point corresponds to an individual sample, and bars indicate mean values (N= 50 samples per group).Reprogramming of the metabolic network is now considered
to be a hallmark of neoplastic transformation (Hanahan and
Weinberg, 2011). However, altered expressions of metabolic
genes are very heterogeneous across different tumor types in
that there is no uniformmetabolic variation associated with all tu-
mors (Hu et al., 2013). Accumulating evidence indicates that ma-
lignant transformation is associated with changes that affect
several branches of metabolism to support, on the one hand,
the energy demands of cancer cells and, on the other, the ana-
plerotic reactions that are ultimately required for the generation
of sufficient building blocks (i.e., nucleic acids, proteins, and
membranes) (Galluzzi et al., 2013; Smolkova´ et al., 2011; Ward3632 Cell Reports 23, 3621–3634, June 19, 2018and Thompson, 2012). Here, we show that reprogramming of
the energy metabolism could occur during the initial phase of
carcinogenesis to support keratinocyte responses to UVB irradi-
ation. Some metabolic modifications including DHODH activa-
tion, which occur at a very early phase of UVB-induced tumori-
genesis (i.e., hyperplasia), persist during the subsequent steps
of carcinogenesis (Figures 1B, 1E, and 7) probably owing to
the need for supporting energy demands and anaplerotic reac-
tions of keratinocytes. On the other hand, some other metabolic
changes found at the initial phase of carcinogenesis, such
as downregulation of glycolysis and upregulation of lipid
biosynthesis, can remodify in the final stage of carcinogenesis
(Figures 1B and 1E) possibly owing to the inactivation of a tumor
suppressor gene, activation of an oncogene, and/or adaptation
to the tumor microenvironment. In support to the first notion, in-
activated DHODH or impaired ETC blocks neoplastic transfor-
mation of keratinocytes. Consistent with our results, treatment
of mice with metformin, which interrupts themitochondrial respi-
ratory chain at complex I, resulted in the significant delayed
onset of UVB- and chemical-induced skin tumorigenesis and
the reduced tumor multiplicity (Checkley et al., 2014; Wu et al.,
2013). Growth of UVB-induced established tumors has also
been shown to be slowed down following treatment with metfor-
min (Wu et al., 2013). In addition, upregulation and overactivation
of DHODH have been reported in several types of cancers (Ahn
and Metallo, 2015; He et al., 2014; Hu et al., 2013; White et al.,
2011; Zhai et al., 2013). In accordance, inhibition of DHODH or
knockout of Tfam have been demonstrated to reduce tumor
growth (Weinberg et al., 2010; White et al., 2011; Zhai et al.,
2013). In support of the second notion, increased expression
of enzymes involved in glycolysis in SCC could be related to
the overexpression of hypoxia inducible factor (HIF)-1a
(Figure 7A).
Altogether, our findings highlight the dynamic role of mitochon-
dria in the regulation of UVB-induced carcinogenesis. Our results
also suggest that modifications in energy metabolism can be ex-
ploited for skin tumor prevention and curative treatment.
EXPERIMENTAL PROCEDURES
Animals and Experimental Protocol
SKH-1 hairless mice were purchased at 4–6 weeks of age from Charles
River (L’arbresle, France). Tfamflox/flox mice were kindly provided by
Dr. Nils-Go¨ran Larsson, Max Planck Institute for Biology of Aging, Cologne
Germany. K14-Cre-ERT2 mice expressing inducible Cre recombinase under
the control of the keratinocyte-specific K14 promoter (K14-Cre) were pur-
chased from Jackson Laboratory. Hairless Tfamflox/flox mice and Hairless
K14-Cre-ERT2 mice were generated by cross-breeding with hairless
SKH-1 mice for 5 generations. The progeny was genotyped by PCR
assays on tail DNA. Crossing these strains then generated the K14-Cre-
ERT2/Tfamflox/flox. Mice in which TFAM deficiency was restricted to kerati-
nocytes were then generated by topical skin application of 4-hydroxy-
tamoxifen (OHT) at 1 mg kg1 for 5 consecutive days. Tfam ablation in
keratinocytes was verified by PCR assays on skin DNA (Figure S5). Mice
were bred and maintained in a pathogen-free mouse facility. All mouse ex-
periments were carried out with the approval of Bordeaux University Animal
Care and Use Committee. In all experiments, female mice were used. Mice
were randomly assigned to each group before the start and experiments
were performed blinded with respect to genotype and/or treatment.
Chronic irradiation was started at age 7–9 weeks.
Cellular O2/CO2 Exchange
A Seahorse XF24 Extracellular Flux Analyzer (Seahorse Bioscience) was used
to analyze the bioenergetic function of skin samples. Results were normalized
with weight of skin samples for potential differences in skin size. Slices on
nylon inserts were individually inserted face down into 20 wells of 24-well XF
Islet Capture Microplates that contained 500 mL of assay medium. The assay
medium for measurement of glycolytic capacity was XF Base medium (Sigma)
supplemented with penicillin (100 IU/mL) and streptomycin (100 mg/mL)
adjusted to pH 7.4. The assay medium for measurement of OXPHOS capacity
consisted in XF Base medium supplemented with D-glucose (11 mM), sodium
pyruvate (1 mM), penicillin (100 IU/mL), and streptomycin (100 mg/mL)
adjusted to pH 7.4 for measurement of OCR or ECAR. For fatty acid b-oxida-
tion, skin samples were put in a modified Krebs-Henseleit-bicarbonate buffer
(KHB) supplemented with 2.5 mM glucose, 50 mM carnitine, and 5 mMHEPESadjusted to pH 7.4. Four wells contained inserts but no skin samples to control
for temperature-sensitive fluctuations in O2 fluorophore emission. Once the
transfer of inserts was complete, samples in XF Islet Capture Microplates
were incubated in a CO2-free incubator at 37
C for 1 hr to allow temperature
and pH equilibration.Microplates were then put into XF24 and allowed to equil-
ibrate for 15 min prior to first measurement. XF assays consisted of 3 min mix,
3 min wait, and 2 min measurement cycles and were performed at 37C as
described elsewhere (Wu et al., 2007). Using this protocol, it was possible to
calculate an O2 consumption rate every 8 min. Drugs of interest prepared in
the requisite assay medium (75 m^ ) were preloaded into reagent delivery cham-
bers A, B, C, and D at 103, 113, 123, and 133 the final working concentra-
tion, respectively, and injected sequentially at intervals of 24 min as indicated.
The substrates were added as indicated in the figures at the following final
working concentrations: oligomycin (25 mM), rotenone (25 mM), antimycin A
(50 mM), digitonin (4 mM), succinate (25 mM), DNP (100 mM), dihydroorotic
acid (10 mM), and etomoxir (200 mM). The optimal concentration of drugs
and skin size was determined following titration assays (Table S3). In each
24-well plate, both non-irradiated and irradiated samples were put in triplicate.
The consumption of oxygen by irradiated samples were then compared with
those of non-irradiated skin in the same plate by setting the consumption of
oxygen by non-irradiated skin in each plate to 100%.
Proteomic Analysis
Sample preparation, nano-scale liquid chromatographic tandem mass spec-
trometry analysis, database search, processing of results, and label-free
quantitative data analysis are detailed in the Supplemental Information.
Statistics
Comparisons between two groups were calculated using Student’s t test (two
tailed) and a p value < 0.05 (*) was considered significant. Results are pre-
sented as means ± SD. Comparisons between more than two groups were
calculated with one-way ANOVA followed byBonferroni’s multiple comparison
tests. To assess theOCRdata, the number and the volume of tumors, two-way
ANOVA followed by a post hoc Tukey’s test was used. A p value < 0.05 (*) was
considered significant. Results are presented as means ± SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2018.05.060.
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